Innovating for screening
Screening to prevent, treat and cure
Assistance in the
interpretation of data
Automate biological screening, improve its efficiency, reduce mortality, while reducing the cost of analysis
Integrative and scalable biomedical analysis solutions that we adapt to your needs
High analytical sensitivity
Low costs of analysis
Robustness and traceability
Latest news and eventsSee the latest news
NeoSickle makes a successful transition to the new IVD regulations
Detection of a new case of Hb Wanjiang.
Biomaneo becomes a subsidiary of Shimadzu Corporation
4th Global Congress on Sickle Cell Disease
Biomaneo obtains ISO 13485:2016 certification and strengthens its quality team
New NeoSickle installation
Biomaneo puts the spotlight on the training of young people...
Biomaneo obtains the "Label Initiative Remarquable"
A new shareholder into our business